These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1649728)

  • 1. Oral sodium regulates extrahepatic metabolism of vasoactive intestinal peptide.
    Hawley CM; Duggan KA; Macdonald GJ; Shelley S
    Clin Sci (Lond); 1991 Jul; 81(1):79-83. PubMed ID: 1649728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute but not chronic gastric sodium administration regulates vasoactive intestinal peptide metabolism by the liver.
    Hawley CM; Duggan KA; MacDonald GJ; Shelley S
    Acta Physiol Scand; 1991 Nov; 143(3):295-8. PubMed ID: 1772038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II regulates the metabolism but not the secretion of vasoactive intestinal peptide in the rabbit.
    Davis RE; Macdonald GJ; Duggan KA
    Clin Sci (Lond); 1992 Nov; 83(5):557-60. PubMed ID: 1335391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of vasoactive intestinal peptide release and metabolism by sodium.
    Duggan KA; Shelley S; Macdonald GJ
    J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S21-3. PubMed ID: 1708016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of a high sodium diet on the metabolism and secretion of vasoactive intestinal peptide in the rabbit.
    Davis RE; Shelley S; MacDonald GJ; Duggan KA
    J Physiol; 1992; 451():17-23. PubMed ID: 1403810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium depletion decreases hepatic metabolism of vasoactive intestinal peptide in the rabbit.
    Duggan KA; Hawley CM; Macdonald GJ; Shelley S
    J Physiol; 1989 Nov; 418():251-9. PubMed ID: 2621618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive intestinal peptide regulates angiotensin II catabolism in the rabbit.
    Davis RE; Ye VZ; Macdonald GJ; Duggan KA
    Acta Physiol Scand; 1995 Mar; 153(3):255-61. PubMed ID: 7625178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunoassay study of hepatic clearance and disappearance half-time of somatostatin and vasoactive intestinal peptide in dogs.
    Chayvialle JA; Rayford PL; Thompson JC
    Gut; 1981 Sep; 22(9):732-7. PubMed ID: 6117506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation of the renin-angiotensin system in regulating the excretory response to acute sodium ingestion.
    Duggan KA; Jones DM; MacDonald GJ
    Clin Exp Pharmacol Physiol; 1995; 22(6-7):455-6. PubMed ID: 8582101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary clearance of vasoactive intestinal peptide.
    Barrowcliffe MP; Morice A; Jones JG; Sever PS
    Thorax; 1986 Feb; 41(2):88-93. PubMed ID: 3010486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sodium depletion on tissue concentrations of the natriuretic hormone vasoactive intestinal peptide.
    Duggan KA; Ye VZ
    Clin Exp Pharmacol Physiol; 1995 Aug; 22(8):583-4. PubMed ID: 7586717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms underlying the decrease in circulating angiotensin II concentration after sodium loading.
    Duggan KA; Ye VZ
    Clin Exp Pharmacol Physiol; 1998 Oct; 25(10):818-9. PubMed ID: 9784922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of dietary sodium on the concentrations of vasoactive intestinal peptide in plasma and lung.
    Ye VZ; Duggan KA
    Chest; 1995 Aug; 108(2):535-8. PubMed ID: 7634895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance P, vasoactive intestinal polypeptide, and gastrin catabolism in canine liver and kidney.
    Kabemura T; Misawa T; Chijiiwa Y; Nasu T; Nawata H
    Dig Dis Sci; 1992 Nov; 37(11):1661-5. PubMed ID: 1385057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of effect of dietary salt on prehepatic first-pass metabolism: effects of beta-blockade and intravenous salt loading.
    Fromm MF; Darbar D; Dell'Orto S; Roden DM
    J Pharmacol Exp Ther; 1999 Jul; 290(1):253-8. PubMed ID: 10381784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vasoactive intestinal peptide on gastric secretion in the cat.
    Vagne M; Konturek SJ; Chayvialle JA
    Gastroenterology; 1982 Jul; 83(1 Pt 2):250-5. PubMed ID: 6806139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of endopeptidase 24.11 inhibition on plasma and tissue concentrations of vasoactive intestinal peptide.
    Duggan KA; Jones DM; Ye VZ; Davis RE; Macdonald GJ
    Clin Sci (Lond); 1995 Sep; 89(3):267-71. PubMed ID: 7493422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive intestinal peptide-associated inhibition of stimulated gastric secretion. II. Inhibition of pentagastrin-stimulated gastric secretion.
    Escourrou J; Ebeid AM; Fischer JE
    Am J Surg; 1980 Jun; 139(6):824-8. PubMed ID: 7386737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoreactive somatostatin and vasoactive intestinal peptide in the digestive tract of cats.
    Chayvialle JA; Miyata M; Rayford PL; Thompson JC
    Gastroenterology; 1980 Nov; 79(5 Pt 1):837-43. PubMed ID: 6106619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial vasoactive intestinal peptide and fibrosis induced by nitric oxide synthase inhibition in the rat.
    Ye VZ; Hodge G; Yong JL; Duggan KA
    Acta Physiol Scand; 2003 Dec; 179(4):353-60. PubMed ID: 14656372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.